Free Biopharma Daily Stock Updates - 03/11/21

$XBI $146.95 +4% 📈

Want to access our searchable database of 900 catalysts and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!

Covid Updates

$VIR +32% and $GSK Announced phase 3 results that VIR-7831 reduces hospitalizations and risk of death in early treatment of adults with Covid-19 after IDMC recommended trial stop early due to efficacy. source

$CYDY +15% Phase 2 trial enrolled 20 patients in 10 days, enrollment to be completed this month. source

$RIGL +8% Completes enrollment for trial in hospitalized covid-19 patients. Data expected in April 2021. source

$PDSB +40% Covid-19 vaccine Consortium received commitment from The Ministry of Science of Brazil to fund clinical development. source

Pipeline Updates

$BHVN +5% Completed 50% enrollment ahead of timeline in ph2/3 trial of verdiperstat in ALS. source

$BHVN +5% Nurtec ODT approved in United Arab Emirates for acute treatment of migrain. source

$BTAI +4% NDA submitted for BXCL501 for agitation associated with schizo and BD. FDA decision expected by 5/10/21. source

$SPPI +19% FDA grants Fast Track Designation for poziotinib for the treatment of NSCLC in previously treated patients with HER2 exon 20 mutations. NDA expected to be submitted later this year. source

$ALKS +2% FDA grants Orphan Drug Designation to nemvaleukin alfa for the treatment of mucosal melanoma. source

$PHAS +10% Enters into supply agreement to support development and commercialization of bentracimab with BioVectra Inc. source

Finance Updates

$ENDP +6% Private offering


*Disclaimer: Information provided on and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.